Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice-Reference-Cited by-同舟云学术

Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice

Published:2021-02-10 Issue:4 Volume:19 Page:1001-1017
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Ngo Anh T. P.¹^ORCID,Jordan Kelley R.²,Mueller Paul A.²,Hagen Matthew W.²^ORCID,Reitsma Stéphanie E.¹,Puy Cristina¹^ORCID,Revenko Alexey S.³,Lorentz Christina U.¹⁴,Tucker Erik I.¹⁴,Cheng Quifang⁵,Hinds Monica T.¹,Fazio Sergio²,Monia Brett P.³,Gailani David⁵,Gruber András¹⁴,Tavori Hagai²,McCarty Owen J. T.¹

Affiliation:

1. Department of Biomedical Engineering School of Medicine Oregon Health and Science University Portland OR USA

2. Knight Cardiovascular Institute Oregon Health and Science University Portland OR USA

3. Ionis Pharmaceuticals Inc Carlsbad CA USA

4. Aronora Inc Portland OR USA

5. Department of Pathology, Microbiology, and Immunology Vanderbilt University Nashville TN USA

Funder

NIH Clinical Center

Publisher

Wiley

Subject

Hematology